| TTM
|
12/31/2025
|
12/31/2024
|
12/31/2023
|
12/31/2022
|
|
|---|---|---|---|---|---|
| Total Revenue
|
83,119,789 | 91,848,234 | 119,924,617 | 103,527,201 | 95,100,568 |
| Cost of Revenue
|
-73,043,453 | -82,472,567 | -113,326,658 | -98,169,881 | -89,720,344 |
|
Gross Profit
|
10,076,336 | 9,375,667 | 6,597,959 | 5,357,320 | 5,380,224 |
| Selling, General and Administrative Expenses
|
-2,007,226 | -2,042,300 | -1,904,015 | -1,665,745 | -1,701,823 |
|
Research and Development Expenses
|
-208,586 | -143,640 | -113,486 | -132,252 | -136,925 |
|
Operating Income/Expenses
|
-2,215,812 | -2,185,940 | -2,017,501 | -1,797,997 | -1,838,748 |
|
Total Operating Profit/Loss
|
7,860,524 | 7,189,727 | 4,580,458 | 3,559,323 | 3,541,476 |
| Total Net Finance Income/Expense
|
-435,526 | -652,661 | -593,699 | -395,835 | -172,074 |
| Net Investment Income
|
329,278 | 423,128 | 437,396 | 426,094 | 250,342 |
| Irregular Income/Expenses
|
-140,955 | -3,139,144 | -249,949 | -280,364 | 3,557 |
|
Other Income/Expense, Non-Operating
|
618,514 | 261,886 | 205,434 | 192,477 | 344,142 |
|
Non-Operating Income/Expenses, Total
|
371,311 | -3,106,791 | -200,818 | -57,628 | 425,967 |
|
Pretax Income
|
8,231,835 | 4,082,936 | 4,379,640 | 3,501,695 | 3,967,443 |
|
Provision for Income Tax
|
-2,077,647 | -1,325,677 | -1,444,724 | -646,369 | -697,366 |
|
Net Income from Continuing Operations
|
6,154,188 | 2,757,259 | 2,934,916 | 2,855,326 | 3,270,077 |
|
Net Income after Extraordinary Items and Discontinued Operations
|
6,154,188 | 2,757,259 | 2,934,916 | 2,855,326 | 3,270,077 |
|
Non-Controlling/Minority Interests
|
-1,041,347 | -1,065,898 | -992,533 | -964,010 | -890,779 |
|
Net Income after Non-Controlling/Minority Interests
|
5,112,841 | 1,691,361 | 1,942,383 | 1,891,316 | 2,379,298 |
|
Net Income Available to Common Stockholders
|
5,112,841 | 1,691,361 | 1,942,383 | 1,891,316 | 2,379,298 |
|
Diluted Net Income Available to Common Stockholders
|
5,112,841 | 1,691,361 | 1,942,383 | 1,891,316 | 2,379,298 |
| Basic EPS
|
5.59 | 1.87 | 2.17 | 2.13 | 2.74 |
| Diluted EPS
|
4.92 | 1.69 | 1.93 | 2.10 | 2.70 |
|
Basic Weighted Average Shares Outstanding
|
914,382.43 | 902,422.09 | 895,672.84 | 887,237.83 | 868,928.72 |
|
Diluted Weighted Average Shares Outstanding
|
1,082,617.18 | 1,002,108.07 | 1,004,790.18 | 902,339.39 | 880,399.78 |
| Income Statement, Supplemental
|
|||||
|
EBIT
|
8,667,361 | 4,735,597 | 4,973,339 | 3,897,530 | 4,139,517 |
|
EBITDA
|
9,911,501 | 6,004,292 | 6,273,838 | 5,114,622 | 5,301,153 |
|
Normalized EBITDA
|
9,411,362 | 8,840,975 | 6,477,607 | 5,370,227 | 5,496,982 |
|
Normalized Income
|
5,780,280.08 | 4,672,907.91 | 3,071,467.11 | 3,063,749.64 | 3,431,484.75 |
|
Total Unusual Items
|
-500,139 | 2,836,683 | 203,769 | 255,605 | 195,829 |
12/31/2022 - 1/4/2000
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
Upgrade